Background Few studies have investigated patient-reported non-motor outcomes after stroke in young adults. We aimed to assess ...
The SISAQOL-IMI consortium, co-led by the European Organization for Research and Treatment of Cancer (EORTC) and Boehringer Ingelheim (BI), has published a paper in The Lancet Oncology outlining how ...
Solutions Market is expanding due to rapid digitalization in clinical research, the reliance on patient-reported outcomes, and increasing regulatory compliance requirements.Austin, Texas, Dec. 14, ...
Patient-reported outcome measures (PROMs) reflect patients’ abilities, difficulties and perceptions, but their use in ...
Analysis of the phase 3 explorer7 (NCT04083781) study indicates a preference for concizumab prophylaxis over no prophylaxis in patients with hemophilia A or B with inhibitors. Among individuals with ...
Patients with Sjögren disease (SjD) — whether seropositive or seronegative for anti-SSA/Ro and anti-SSB/La antibodies — experience systemic disease activity and symptom burden that are closely tied to ...
When patients provide information about how they are doing, including symptoms, functionality, and quality of life, scientists can use this data, called patient-reported outcomes (PROs), to conduct ...
Efficacy and Safety of Disitamab Vedotin in Patients With Human Epidermal Growth Factor Receptor 2–Positive Locally Advanced or Metastatic Urothelial Carcinoma: A Combined Analysis of Two Phase II ...
In the age of AI, ePROs and wearable biosensors may transform the way patient data is collected and analysed in clinical ...
Innovative smart pill bottles significantly enhance adherence to oral adjuvant endocrine therapy in early-stage breast cancer ...